Drawing for PATHOQUEST

USPTO serial 79195950

PATHOQUEST

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
RIEPEL, CHRISTINA MAXINE
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with PATHOQUEST?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Anna L. King

ANNA L KING BANNER & WITCOFF LTD71 SOUTH WACKER DRIVE, SUITE 3600CHICAGO, IL 60606UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Computers; computer systems, namely, software for compiling scientific and biological data and electronic databases recorded on computer media in the field of laboratory analysis and diagnostics; computer systems, namely, software for analyzing scientific and biological data and electronic databases recorded on computer media for scientific and biological use; computer systems comprised of computer hardware and peripherals and software for collecting, storing, analysis and reporting of biological information, and follow-up projects and monitoring of samples, workflows and laboratory data; chemical and biological analysis software; software for collecting, storing, analyzing, monitoring, and reporting and electronic databases recorded on computer media, all of the foregoing dedicated to the fields of diagnostics and metagenomics; software for detecting and analyzing of pathogens in a biological sample and electronic databases referencing publicly available collections of genomic information on bacteria and viruses recorded on computer media; laboratory apparatus and instruments for the detection of pathogens in a biological sampleABANDONED—
042Scientific testing services, namely, for testing and analysis in the field of DNA analysis; medical testing services in the field of pharmaceutical testing; microbiological testing services, namely, providing microbiological sample testing for others in the fields of medicine and research related thereto; computer-aided testing services, namely, genetic testing for research purposes; collection and analysis of blood for scientific purposes; preparation of biological samples to be analyzed in a laboratory; conducting analysis and products testing in the biological, pharmaceutical and bio-pharmaceutical fields; analysis and evaluation of the toxicity and safety of biological and pharmaceutical products, and their components; conducting analyses and tests by metagenomics; arranging and conducting of scientific and technical reports; advisory services relating to laboratory tests; scientific and medical laboratory services; services of laboratory for the preparation, detection, quantification and analysis of biological materials, for genotyping, for diagnostic tests and for the sequencing of biological molecules, genomes and metagenomes; laboratory services for DNA analysis; biological, bacteriological, medical and pharmacological research services; design, development and updating of software and databases dedicated to the fields of diagnostics and metagenomics; research and development in the field of genome research and genetic expression; biotechnology research and developmentABANDONED—
044Medical diagnostic services, namely, testing and analysis in the field of disease diagnosis; collection and analyses of human blood for medical purposes; preparing and processing biological samples for medical and pharmaceutical use intended for analysis in laboratories, namely, disease diagnostics; medical analysis in the nature of medical testing for diagnosis; medical analysis in the nature of medical testing of biological molecules, genomes and metagenomes for diagnosing of pathogens and infectious diseases; medical and health services relating to DNA, genetics and genetic testing, namely, genetic counseling and genetic testing for medical purposes; DNA analysis services for medical purposes; preparation and compilation of medical reports; medical testing services relating to disease diagnosis and treatment; medical analysis services for the diagnosis and treatment of persons; carrying out disease diagnoses; medical testing for the diagnosis and treatment of personsABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 27, 2021LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Jan 3, 2021RHRDRESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED—
Mar 20, 2020FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 5, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 5, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 29, 2019LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Sep 19, 2019RHRDRESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED—
Mar 5, 2019MAB4ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION—
Mar 5, 2019ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Mar 5, 2019OP.TOPPOSITION TERMINATED NO. 999999—
Mar 5, 2019OP.SOPPOSITION SUSTAINED NO. 999999—
Feb 7, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 27, 2018OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Apr 20, 2018RFNTREFUSAL PROCESSED BY IB—
Apr 11, 2018OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 11, 2018OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Mar 27, 2018OP.IOPPOSITION INSTITUTED NO. 999999—
Mar 26, 2018OPNSOPPOSITION NOTICE (IB REFUSAL) SENT TO IB—
Mar 24, 2018OPNCOPPOSITION NOTICE (IB REFUSAL) CREATED—
Oct 18, 2017ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Sep 26, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 26, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 6, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 11, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 11, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 11, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 11, 2017ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Apr 11, 2017GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Apr 11, 2017GNSLLETTER OF SUSPENSION E-MAILED—
Apr 11, 2017CNSLSUSPENSION LETTER WRITTEN—
Apr 11, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 10, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 10, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 17, 2016RFNTREFUSAL PROCESSED BY IB—
Nov 28, 2016RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 28, 2016RFRRREFUSAL PROCESSED BY MPU—
Nov 24, 2016RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 23, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 22, 2016MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 16, 2016DOCKASSIGNED TO EXAMINER—
Nov 16, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 10, 2016REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance